TELADOC HEALTH, INC. (TDOC) FY2026 YTD Q3 P&L / Income Statement
Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)
Revenue by Product and Service
Swipe to see the full flow
Chart details
TELADOC HEALTH, INC. (TDOC) FY2026 YTD Q3 P&L / Income Statement
Income statement for 2026-01-01 through 2026-09-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Revenue
- 1,825,874,000 US dollars
- Cost of revenue (calculated)
- 578,621,000 US dollars
- Gross profit (calculated)
- 1,247,253,000 US dollars
- Operating expenses (calculated)
- 1,374,212,000 US dollars
- Loss from operations
- negative 126,959,000 US dollars
- Other income (expense), net (calculated)
- 1,927,000 US dollars
- Loss before provision for income taxes
- negative 125,032,000 US dollars
- Provision for income taxes
- 4,647,000 US dollars
- Net loss
- negative 129,679,000 US dollars
- Access Fees
- 1,425,591,000 US dollars
- Other
- 400,283,000 US dollars
- Cost of revenue (exclusive of depreciation and amortization, which are shown separately below)
- 578,621,000 US dollars
- Depreciation of property and equipment
- 7,115,000 US dollars
- Advertising and marketing
- 418,902,000 US dollars
- Acquisition, integration, and transformation costs
- 4,319,000 US dollars
- Sales
- 150,245,000 US dollars
- Technology and development
- 196,272,000 US dollars
- General and administrative
- 313,522,000 US dollars
- Restructuring costs
- 17,283,000 US dollars
- Amortization of intangible assets
- 266,554,000 US dollars
- Goodwill impairment
- 0 US dollars
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
